Home / People / Sarah Hanson
Picture of Hanson Sarah

Sarah Hanson

Partner

Contact
T +44 20 7367 2559
T +65 6422 2848 (Singapore)
F +44 20 7367 2000
CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
London
EC4N 6AF
United Kingdom
CMS Holborn Asia
7 Straits View
Marina One East Tower
#19-01
Singapore 018936
Languages English
Life Sciences & Healthcare

Sarah Hanson is a Co-head of the Life Sciences & Healthcare Sector Group for CMS Cameron McKenna Nabarro Olswang LLP. She has specialised in high value, cross-border commercial, intellectual property and outsourcing transactions for more than 20 years having advised on a broad range of commercial agreements relating to in and out licensing, sales and distributor arrangements, research and development, manufacturing and supply, strategic alliances and joint ventures.  During her time with the firm she has been on secondment with Warner Lambert (now part of Pfizer). 

more less

Sarah is ranked in Chambers and Partners for Life Sciences: Transactional with a client reporting "We get fast and clear responses from her and good engagement at all stages. We have had a very positive overall experience."

Chambers

"Sarah Hanson has acted as our relationship partner and has always responded quickly and helped to select appropriate advisors within the CMS network for each instruction."

Client Feedback, Legal 500

Sarah Hanson is ranked in Tier 2 as a Leading Practitioner in the lifesciences - Transactional category with client feedback including: "We get fast and clear responses from her and good engagement at all stages. We have had a very positive overall experience."

Chambers and Partners, 2020

Ranked as a Leading Individual for Commercial Contracts.

Legal 500, 2019

Sarah is ranked in Band 2 as a leading practitioner in the Lifesciences – Transactional category where clients say “She never misses a thing” and “could not be more responsive”

Chambers 2018

Sarah was also the exclusive winner of the Healthcare and Lifescience category for the UK of the International Law Office (ILO) Client Choice Awards.

Client Choice Awards

Sarah is ranked in Band 2 as a leading practitioner in the Lifesciences – Transactional category in Chambers where sources say she is “rock solid and praise her for her commercial approach” (2016 edition).

"Sarah is ranked as a leading practitioner for licensing work on the basis that she “has forged a strong name in transactions for patent-rich practitioners”."

IAM 1000 top patent practitioners.

Sarah has been recommended in a number of directories including PLC which Lawyer? Lifesciences the PLC Lifesciences Handbook and Legal 500 that described her as “delightful, very responsive and helpful”.

Sarah is ranked as a leading individual in Who’s Who Legal: Lifesciences – Transactional (2016 edition).

Relevant experience

  • Almirall SA on the transfer of its respiratory franchise to AstraZeneca for an initial consideration of USD 875m on completion and up to USD 1.22bn in development, launch and sales related milestone payments.
  • PGT Healthcare LLP in relation to a collaboration with Swisse Wellness Group Party Limited in relation to vitamin, mineral and food supplement products across certain territories.
  • Sinclair IS Pharma plc on an exclusive 100 year distribution arrangement with an affiliate of Valeant Pharmaceuticals International, Inc, for injectable aesthetic dermal filler products in Western Europe.
  • Takeda Pharmaceutical on its EUR 9.6bn (debt-free cash free) acquisition of Swiss drug company, Nycomed.
  • Futura Medical, an AIM listed company, in relation to the licensing of its CSD500 product to major pharmaceutical and healthcare group, including Church & Dwight and Ansell.  We have advised on the commercial agreements with contract manufacturers and own brand labellers as well as the associated technical and quality agreements.
  • On the establishment of the Francis Crick Institute, a consortium of Cancer Research UK, the MRC, UCL and the Wellcome Trust, as a world leading establishment for medical research and innovation at Kings Cross, London, together with ongoing operational advice.
  • Nestlé Health Science on its licence agreement with Lipid Therapeutics for exclusive rights to develop and commercialise a new therapeutic for treating mild to moderate ulcerative colitis.
  • hVIVO plc, an AIM listed company, on its interests in PrEP Biopharm and also on PrEP Biopharm’s licensing arrangements with Janssen Pharmaceuticals with respect to technologies to be developed and commercialised for the treatment of a variety of respiratory viruses.
  • Bayer Crop Science in relation to the sale of its Norwich based manufacturing business (now Briar Chemicals Limited) to the Aurelius Group.
  • Chugui Pharma Marketing in relation to the license of exclusive commercialisation rights to Swiss based Helsiun group’s innovative ghrelin receptor agonist, anamorelin, for the three major European  pharmaceutical markets.
more less

Education

  • 2004 – Intellectual Property Diploma, Bristol University, Bristol
  • 1994 – Distinction, The College of Law, LPC, Chester
  • 1993 – BA (Hons) Cantab Law 2:1, St John’s College, Cambridge
more less

Memberships

  • ABHI
  • ABPI
  • Biotech Industry Association
  • Society for Computers & Law
  • TechUK
more less

Publications

  • European Biopharmaceutical Review – eHealth opportunities for the biopharmaceutical industry
more less

Lectures list

  • EU Pharma Law Conference – May 2015
more less
TMT - Technology, Media & Telecommunications

Sarah Hanson is a Partner in the technology team and is a representative on the management committee of the CMS Commercial Law Group as well as being an active member of the firm’s Technology, Media and Communications sector group.

Sarah Hanson is a Co-head of the Life Sciences & Healthcare Sector Group for CMS Cameron McKenna Nabarro Olswang LLP. 

She has specialised in high value, cross-border commercial, intellectual property and outsourcing transactions for more than 20 years having advised on a broad range of commercial agreements relating to in and out licensing, sales and distributor arrangements, research and development, manufacturing and supply, strategic alliances and joint ventures.  She also provides data privacy advice to clients on a broad range of issues.

more less

Sarah is ranked as a Leading Individual in Legal 500 for Commercial Contracts with a client reporting "Sarah Hanson has acted as our relationship partner and has always responded quickly and helped to select appropriate advisors within the CMS network for each instruction."

Legal 500

"Sarah Hanson has acted as our relationship partner and has always responded quickly and helped to select appropriate advisors within the CMS network for each instruction."

Client Feedback, Legal 500

Sarah Hanson is ranked in Tier 2 as a Leading Practitioner in the lifesciences - Transactional category with client feedback including: "We get fast and clear responses from her and good engagement at all stages. We have had a very positive overall experience."

Chambers and Partners, 2020

Ranked as a Leading Individual for Commercial Contracts.

Legal 500, 2019

Sarah is ranked in Band 2 as a leading practitioner in the Lifesciences – Transactional category where clients say “She never misses a thing” and “could not be more responsive”

Chambers 2018

Sarah was also the exclusive winner of the Healthcare and Lifescience category for the UK of the International Law Office (ILO) Client Choice Awards.

Client Choice Awards

Sarah is ranked in Band 2 as a leading practitioner in the Lifesciences – Transactional category in Chambers where sources say she is “rock solid and praise her for her commercial approach” (2016 edition).

"Sarah is ranked as a leading practitioner for licensing work on the basis that she “has forged a strong name in transactions for patent-rich practitioners”."

IAM 1000 top patent practitioners.

Sarah has been recommended in a number of directories including PLC which Lawyer? Lifesciences the PLC Lifesciences Handbook and Legal 500 that described her as “delightful, very responsive and helpful”.

Sarah is ranked as a leading individual in Who’s Who Legal: Lifesciences – Transactional (2016 edition).

Relevant experience

  • A retail company in relation to a comprehensive IT transformation project with a value of between GBP 1-2bn.  The new IT operating model involves the appointment of a ‘service integrator’ supplier who will manage and integrate all IT services.  The project also involves appointment of multiple IT “service tower” providers.  This includes the following IT services: (i) End User Computing services; (ii) Network services (telecoms networks across company’s entire estate); (iii) Front Office services (front office IT applications including cash and stock management, retail and stock sales, branch accounting); and (iv) Back Office services (back office IT applications including HR, accounting and finance systems).
  • Camelot in respect of the establishment of the Euro Millions lottery and related matters.
  • A global company on its transformative HR outsourcing to deliver a new technology platform and service delivery model across multiple regions.
  • A healthcare company on the adoption of RFID technology to support the management of the supply chain for the distribution of its products from the manufacturer to end users.
  • An international consumer brands company on its bid for the Boots Consumer Healthcare division including structuring various IP licences and manufacturing arrangements.
  • A well-known consumer products company in the outsourcing of its back office IT functions to a major IT provider.
  • A marketing company in relation to a number of contracts with a major supermarket for the design and implementation of various consumer product campaigns.
  • A UK listed company on the agency agreements to be entered into by it with various distributors across Europe.
  • A household name drinks company on the logistics and warehousing arrangements for the supply of products in Europe. 
  • A major retail company on various matters including advising on the terms and conditions for its Christmas catalogue, the supply arrangements with a significant procurer of goods and the establishment of its gift voucher scheme.
more less

Education

  • 2004 – Intellectual Property Diploma, Bristol University, Bristol
  • 1994 – Distinction, The College of Law, LPC, Chester
  • 1993 – BA (Hons) Cantab Law 2:1, St John’s College, Cambridge
more less

Memberships

  • ABHI
  • ABPI
  • Biotech Industry Association
  • Society for Computers & Law
  • TechUK
more less

Publications

  • European Biopharmaceutical Review – eHealth opportunities for the biopharmaceutical industry
more less

Lectures list

  • EU Pharma Law Conference – May 2015
more less

Feed

Show only
02 June 2020
CMS Ex­pert Guide to pay­ment term le­gis­la­tion
24 August 2018
Gov­ern­ment Is­sues Brexit Tech­nic­al No­tice for Life Sci­ences
On 23 Au­gust 2018, the UK Gov­ern­ment (the "Gov­ern­ment") is­sued the first wave of its tech­nic­al pa­pers de­signed to provide guid­ance to com­pan­ies to help pre­pare for a "No Deal" Brexit. In this scen­ario,...
21 May 2020
CMS Ex­pert Guide to autonom­ous vehicles (AVs)
This CMS Ex­pert Guide brings to­geth­er ana­lys­is from leg­al ex­perts across our in­ter­na­tion­al net­work on the leg­al re­quire­ments that must be ob­served for test­ing and us­ing AVs at dif­fer­ent levels of auto­ma­tion.
27 March 2020
CMS Ex­pert Guide to force ma­jeure
03 February 2020
CMS Ex­pert Guide to 5G reg­u­la­tion and law
5G: Across coun­tries, some tech­nic­al para­met­ers are com­mon; the same can­not be said for reg­u­la­tion. Find here a guide about the key 5G re­lated reg­u­lat­ory po­s­i­tions be­ing taken in 40 jur­is­dic­tions.
28 October 2019
CMS Ex­pert Guide to dis­tri­bu­tion law
Are you look­ing for in­form­a­tion on dis­tri­bu­tion law? This CMS Ex­pert Guide provides you with everything you need to know.
01 November 2015
CMS Ex­pert Guide to war­ranty law in sup­ply con­tracts
The fol­low­ing CMS Guide on War­ranties in Sup­ply Con­tracts il­lus­trates the leg­al con­di­tions for sup­ply agree­ments in sev­er­al European coun­tries.